less than 9% of all cases metastasise to the brain (Sanghvi et. al. 2017) .
52
Up to 15-25% of brain tumours diagnosed are a metastasis (Bekaert et. al. 2017 ).
53
Whilst 80% of patients have a known primary, for some patients the identification of 54 metastasis may be the initial presentation of the primary tumour (Bekaert et. al. 55 2017). It is thought that the actual incidence of brain metastases is higher than 56 reported as some may go undiagnosed. For those who undergo metastectomy for 57 diagnosis or symptom relief, the tissue, once removed is sent for histopathological 58 analysis to determine the location of the primary tumour. 
101
Outside of the brain, the use of spectroscopy on both tissue and blood components has Following this, they were immersed in fresh ethanol at 100% twice and then 70% 134 ethanol once, for 5 min each, and then allowed to air dry prior to spectral acquisition.
135
H&E-stained slides were viewed to delineate the tumour to be examined, to reduce 136 contamination of spectra from background brain tissue. were selected at random moving over the tissue. 
Results

166
Analysis of the spectra has shown similar results for both Raman and ATR-FTIR 167 spectroscopy. They demonstrate similar spectral appearances for both 168 adenocarcinoma groups, with significant differences seen to the spectra of the 169 melanoma. This can be seen primarily within both the pre-processed spectra [see show the difficulty in separating the adenocarcinomas. When using three groups for Table S2 ).
10
The statistical significance between each group was also calculated using a one-way
207
Anova (see SI Table S1 ). This highlights the statistically significant differences found 208 between adenocarcinoma and melanoma. There is no statistical difference between 209 the two adenocarcinoma groups on either Raman or ATR-FTIR spectroscopy.
210
To conclude, the significant differences were calculated (see Figure 7 ) and tentative 211 distinguishing wavenumbers assigned to those differences ( This study has highlighted both forms of spectroscopy are able to differentiate 260 different tumour types such as melanoma versus adenocarcinoma. However, it is not 261 able to differentiate tumour types to determine primary tissue origin of a metastasis in 262 its current form.
263
As the technique develops, it may eventually be able to provide additional 264 information to support the initial histopathological diagnosis, which may in the future 265 provide treatment related or prognostic information once the spectra are fully 266 understood in the years to come.
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